STAT

Here’s your cheat sheet to the latest version of Graham-Cassidy health care reform

The last-ditch GOP effort to repeal the Affordable Care Act is still alive. Barely. Here’s a look at key provisions in the updated Graham-Cassidy bill.
Sen. Bill Cassidy (R-La.) is leading a last-ditch Republican effort to repeal the Affordable Care Act.

WASHINGTON — The last-ditch Republican effort to repeal the Affordable Care Act is still alive.

The substance of the new proposal is substantially different from the repeal bills that nearly became law earlier this year. Nonetheless, many of the same questions remain.

The bill would deregulate individual insurance markets, slash Medicaid spending, and make it much harder for states to preserve their existing health programs. It could raise costs for Americans with preexisting conditions, limit access to addiction treatment, and reduce spending on public health campaigns, such as childhood vaccinations.

Just as they did this summer, senators on Sunday circulated last-minute changes aimed solely at bringing reluctant colleagues on board. Once again, the new bill includes more money for Alaska and Maine — where senators have voiced major concerns about the bill — and removes consumer protections that conservatives condemn

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.

Related Books & Audiobooks